LPS-treated macrophage cytokines repress surfactant protein-B in lung epithelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 49, Issue 2, 2013, Pages 306-315

  Bein, Kiflai ^a   Di Giuseppe, Michelangelo ^a   Mischler, Steven E ^a   Ortiz, Luis A ^a   Leikauf, George D ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Sepsis; Surfactant; TNF

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; RECOMBINANT TUMOR NECROSIS FACTOR; SMALL INTERFERING RNA; SURFACTANT PROTEIN B; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; GENE ACTIVITY; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MICE; PROMOTER REGIONS, GENETIC; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; RESPIRATORY MUCOSA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883149391     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0283OC     Document Type: Article

References (72)

1. Clark JC,Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, Whitsett JA. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995;92: 7794-7798.
2. Stahlman MT, Gray MP, Falconieri MW, Whitsett JA, Weaver TE. Lamellar body formation in normal and surfactant protein B-deficient fetal mice. Lab Invest 2000;80: 395-403.
3. Vorbroker DK, Profitt SA, Nogee LM, Whitsett JA. Aberrant processing of surfactant protein C in hereditary SP-B deficiency. Am J Physiol 1995;268:L647-L656.
4. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009;12: 253-274.
5. Gregory TJ, LongmoreWJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA III, Hudson LD, Maunder RJ, Crim C, Hyers TM. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88: 1976-1981.
6. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999;160: 1843-1850.
7. Pison U, Obertacke U, Brand M, Seeger W, Joka T, Bruch J, Schmit- Neuerburg KP. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 1990;30: 19-26.
8. Veldhuizen RA, McCaig LA, Akino T, Lewis JF. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;152: 1867-1871.
9. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996;153: 176-184.
10. Beers MF, Atochina EN, Preston AM, Beck JM. Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice. J Lab ClinMed 1999;133: 423-433.
11. Ingenito EP,Mora R, Cullivan M, Marzan Y,Haley K,Mark L, Sonna LA. Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury. Am J Respir CellMol Biol 2001; 25: 35-44.
12. Sparkman L, Chandru H, Boggaram V. Ceramide decreases surfactant protein B gene expression via downregulation of TTF-1 DNA binding activity. Am J Physiol Lung Cell Mol Physiol 2006;290:L351-L358.
13. Wispe JR, Clark JC, Warner BB, Fajardo D, Hull WE, Holtzman RB, Whitsett JA. Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J Clin Invest 1990;86: 1954-1960.
14. Yang L, Yan D, Yan C, Du H. Peroxisome proliferator-activated receptor gamma and ligands inhibit surfactant protein B gene expression in the lung. J Biol Chem 2003;278: 36841-36847.
15. Park SK, Dahmer MK, Quasney MW. MAPK and JAK-STAT signaling pathways are involved in the oxidative stress-induced decrease in expression of surfactant protein genes. Cell Physiol Biochem 2012; 30: 334-346.
16. Sugahara K, Sadohara T, Sugita M, Iyama K, Takiguchi M. Differential expression of CCAAT enhancer binding protein family in rat alveolar epithelial cell proliferation and in acute lung injury. Cell Tissue Res 1999;297: 261-270.
17. Alam T, An MR, Papaconstantinou J. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J Biol Chem 1992;267: 5021-5024.
18. Cassel TN, Nord M. C/EBP transcription factors in the lung epithelium. Am J Physiol Lung Cell Mol Physiol 2003;285:L773-L781.
19. Rosenberg E, Li F, Reisher SR, Wang M, Gonzales LW, Ewing JR, Malek S, Ballard PL, Notarfrancesco K, Shuman H, et al. Members of the C/EBP transcription factor family stimulate expression of the human and rat surfactant protein A (SP-A) genes. Biochim Biophys Acta 2002;1575: 82-90.
20. Yan C, Wu M, Cao J, Tang H, Zhu M, Johnson PF, Gao H. Critical role for CCAAT/enhancer-binding protein beta in immune complexinduced acute lung injury. J Immunol 2012;189: 1480-1490.
21. Bein K, Leight H, Leikauf GD. JUN-CCAAT/enhancer-binding protein complexes inhibit surfactant-associated protein B promoter activity. Am J Respir Cell Mol Biol 2011;45: 436-444.
22. O'Reilly MA, Gazdar AF, Morris RE, Whitsett JA. Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line. Biochim Biophys Acta 1988;970: 194-204.
23. O'Reilly MA, Gazdar AF, Clark JC, Pilot-Matias TJ, Wert SE, Hull WM, Whitsett JA. Glucocorticoids regulate surfactant protein synthesis in a pulmonary adenocarcinoma cell line. Am J Physiol 1989;257:L385- L392.
24. Yang L, Lian X, Cowen A, Xu H, Du H, Yan C. Synergy between signal transducer and activator of transcription 3 and retinoic acid receptor- alpha in regulation of the surfactant protein B gene in the lung. Mol Endocrinol 2004;18: 1520-1532.
25. Goodrum KJ, Poulson-Dunlap J. Cytokine responses to group B streptococci induce nitric oxide production in respiratory epithelial cells. Infect Immun 2002;70: 49-54.
26. Krakauer T. Stimulant-dependent modulation of cytokines and chemokines by airway epithelial cells: cross talk between pulmonary epithelial and peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2002;9: 126-131.
27. Tsutsumi-Ishii Y, Nagaoka I. Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharidestimulated mononuclear phagocytes via proinflammatory cytokine production. J Immunol 2003;170: 4226-4236.
28. Das A, Boggaram V. Proteasome dysfunction inhibits surfactant protein gene expression in lung epithelial cells: mechanism of inhibition of SP-B gene expression. Am J Physiol Lung Cell Mol Physiol 2007;292: L74-L84.
29. Beutler B, Cerami A. The biology of cachectin/TNF: a primary mediator of the host response. Annu Rev Immunol 1989;7: 625-655.
30. Goya T, Abe M, Shimura H, Torisu M. Characteristics of alveolar macrophages in experimental septic lung. J Leukoc Biol 1992;52: 236-243.
31. MacKichan ML, DeFranco AL. Role of ceramide in lipopolysaccharide (LPS)-induced signaling: LPS increases ceramide rather than acting as a structural homolog. J Biol Chem 1999;274: 1767-1775.
32. Xaus J, Comalada M, Valledor AF, Lloberas J, Lopez-Soriano F, Argiles JM, Bogdan C, Celada A. LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. Blood 2000; 95: 3823-3831.
33. Pryhuber GS, Church SL, Kroft T, Panchal A, Whitsett JA. 39- untranslated region of SP-B mRNA mediates inhibitory effects of TPA and TNF-alpha on SP-B expression. Am J Physiol 1994;267: L16-L24.
34. Whitsett JA, Clark JC, Wispe JR, Pryhuber GS. Effects of TNF-alpha and phorbol ester on human surfactant protein and MnSOD gene transcription in vitro. Am J Physiol 1992;262:L688-L693.
35. Berhane K, Margana RK, Boggaram V. Characterization of rabbit SP-B promoter region responsive to downregulation by tumor necrosis factor- alpha. Am J Physiol Lung Cell Mol Physiol 2000;279:L806-L814.
36. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489: 57-74.
37. Irish Critical Care Trials Group. Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management. Crit Care 2008;12:R30.
38. Spragg R. Surfactant for acute lung injury. Am J Respir Cell Mol Biol 2007;37: 377-378.
39. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L379-L399.
40. Livraghi A, Randell SH. Cystic fibrosis and other respiratory diseases of impaired mucus clearance. Toxicol Pathol 2007;35: 116-129.
41. Guillot L, Medjane S, Le-Barillec K, Balloy V, Danel C, Chignard M, Si- Tahar M. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem 2004;279: 2712-2718.
42. Keicho N, Elliott WM, Hogg JC, Hayashi S. Adenovirus E1A upregulates interleukin-8 expression induced by endotoxin in pulmonary epithelial cells. Am J Physiol 1997;272:L1046-L1052.
43. Peralta FM, Casale TB. Orientation and presence of epithelium are key to endotoxin-induced neutrophil migration. Eur Respir J 1998;11: 1053-1059.
44. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993;90: 2744-2748.
45. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP III, Toews GB, Westwick J, Strieter RM. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J Clin Invest 1990;86: 1945-1953.
46. DiMango E, Zar HJ, Bryan R, Prince A. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995;96: 2204-2210.
47. Massion PP, Inoue H, Richman-Eisenstat J, Grunberger D, Jorens PG, Housset B, Pittet JF, Wiener-Kronish JP, Nadel JA. Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest 1994;93: 26-32.
48. Nakamura H, Yoshimura K, Jaffe HA, Crystal RG. Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem 1991;266: 19611-19617.
49. Koyama S, Rennard SI, Leikauf GD, Shoji S, Von Essen S, Claassen L, Robbins RA. Endotoxin stimulates bronchial epithelial cells to release chemotactic factors for neutrophils: a potential mechanism for neutrophil recruitment, cytotoxicity, and inhibition of proliferation in bronchial inflammation. J Immunol 1991;147: 4293-4301.
50. Koyama S, Sato E, Nomura H, Kubo K,Miura M, Yamashita T, Nagai S, Izumi T. The potential of various lipopolysaccharides to release IL-8 and G-CSF. Am J Physiol Lung Cell Mol Physiol 2000;278:L658- L666.
51. Schulz C, Farkas L, Wolf K, Kratzel K, Eissner G, Pfeifer M. Differences in LPS-induced activation of bronchial epithelial cells (BEAS-2B) and Type II-like pneumocytes (A-549). Scand J Immunol 2002;56: 294-302.
52. Hedlund M, Frendeus B, Wachtler C, Hang L, Fischer H, Svanborg C. Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells. Mol Microbiol 2001;39: 542-552.
53. Naik S, Kelly EJ, Meijer L, Pettersson S, Sanderson IR. Absence of Tolllike receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr 2001;32: 449-453.
54. Martin TR, Mathison JC, Tobias PS, Leturcq DJ, Moriarty AM, Maunder RJ, Ulevitch RJ. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide: implications for cytokine production in normal and injured lungs. J Clin Invest 1992;90: 2209-2219.
55. Hubbard AK, Timblin CR, Shukla A, Rincon M, Mossman BT. Activation of NF-kappaB-dependent gene expression by silica in lungs of luciferase reporter mice. Am J Physiol Lung Cell Mol Physiol 2002;282:L968- L975.
56. Berg JT, Lee ST, Thepen T, Lee CY, Tsan MF. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphonate. J Appl Physiol 1993;74: 2812-2819.
57. Koay MA, Gao X, Washington MK, Parman KS, Sadikot RT, Blackwell TS, Christman JW. Macrophages are necessary for maximal nuclear factor-kappa B activation in response to endotoxin. Am J Respir Cell Mol Biol 2002;26: 572-578.
58. Kimakhe S, Heymann D, Guicheux J, Pilet P, Giumelli B, Daculsi G. Polymyxin B inhibits biphasic calcium phosphate degradation induced by lipopolysaccharide-activated human monocytes/macrophages. J Biomed Mater Res 1998;40: 336-340.
59. Barrett EG, Johnston C, Oberdorster G, Finkelstein JN. Silica-induced chemokine expression in alveolar Type II cells is mediated by TNFalpha. Am J Physiol 1998;275:L1110-L1119.
60. Chuquimia OD, Petursdottir DH, Periolo N, Fernandez C.Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth. Infect Immun 2013;81: 381-389.
61. Chuquimia OD, Petursdottir DH, Rahman MJ, Hartl K, Singh M, Fernandez C. The role of alveolar epithelial cells in initiating and shaping pulmonary immune responses: communication between innate and adaptive immune systems. PLoS ONE 2012;7:e32125.
62. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992;215: 356-362.
63. Elizur A, Adair-Kirk TL, Kelley DG, Griffin GL, Demello DE, Senior RM. Tumor necrosis factor-alpha from macrophages enhances LPSinduced Clara cell expression of keratinocyte-derived chemokine. Am J Respir Cell Mol Biol 2008;38: 8-15.
64. Spight D, Trapnell B, Zhao B, Berclaz P, Shanley TP. Granulocyte- macrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice. Shock 2008;30: 434-442.
65. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F II, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164: 1896-1903.
66. Elias JA, Zitnik RJ. Cytokine-cytokine interactions in the context of cytokine networking. Am J Respir Cell Mol Biol 1992;7: 365-367.
67. Haczku A, Atochina EN, Tomer Y, Cao Y, Campbell C, Scanlon ST, Russo SJ, Enhorning G, Beers MF. The late asthmatic response is linked with increased surface tension and reduced surfactant protein B in mice. Am J Physiol Lung Cell Mol Physiol 2002;283:L755-L765.
68. Ladenburger A, Seehase M, Kramer BW, ThomasW,Wirbelauer J, Speer CP, Kunzmann S. Glucocorticoids potentiate IL-6-induced SP-B expression in H441 cells by enhancing the JAK-STAT signaling pathway. Am J Physiol Lung Cell Mol Physiol 2010;299:L578-L584.
69. Ballard PL, Liley HG, Gonzales LW, Odom MW, Ammann AJ, Benson B, White RT, Williams MC. Interferon-gamma and synthesis of surfactant components by cultured human fetal lung. Am J Respir Cell Mol Biol 1990;2: 137-143.
70. Ito Y, Mason RJ. The effect of interleukin-13 (IL-13) and interferongamma (IFN-gamma) on expression of surfactant proteins in adult human alveolar Type II cells in vitro. Respir Res 2010;11:157.
71. Reed JA, Ikegami M, Cianciolo ER, Lu W, Cho PS, Hull W, Jobe AH, Whitsett JA. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol 1999;276:L556- L563.
72. Zsengeller ZK, Reed JA, Bachurski CJ, LeVine AM, Forry-Schaudies S, Hirsch R, Whitsett JA. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor- deficient mice. Hum Gene Ther 1998;9: 2101-2109.